CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024

Source: iQoncept / Shutterstock
Champions Oncology (NASDAQ:CSBR) just reported results for the second quarter of 2024.
- Champions Oncology reported earnings per share of -15 cents. This was above the analyst estimate for EPS of -17 cents.
- The company reported revenue of $11.57 million.
- This was 9.87% worse than the analyst estimate for revenue of $12.84 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2023/12/csbr-stock-earnings-champions-oncology-for-q2-of-2024/.
©2023 InvestorPlace Media, LLC